Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Updated
Becker’s Hospital Review
“FDNA uses artificial intelligence to analyze genetic, phenotypic information databases to detect physiological patterns that reveal disease-causing genetic variations.”
The Becker’s Hospital Review article lists leading AI innovators transforming healthcare, with a spotlight on FDNA. FDNA’s groundbreaking technology, Face2Gene, leverages AI to analyze facial features and identify genetic disorders with remarkable accuracy. This clinical decision support tool aids clinicians in diagnosing rare conditions and providing early and precise interventions. Face2Gene exemplifies the growing integration of AI in personalized medicine, significantly improving patient outcomes and clinical efficiency.
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…
Dr. Karen Gripp, Erin Wadman & Carolina Alves talk about the delineation of a new syndrome associated with prenatal fentanyl…